Penicillin Blood-Level Determinations With a Streptococcus dysgalactiae Resistant to Normal Blood Inhibitors

Area of Science:

• Microbiology
• Clinical Chemistry
• Pharmacology

Background:

• Current methods for penicillin blood-level determination use test organisms susceptible to natural inhibitors in human sera.
• This susceptibility can lead to inaccurate penicillin assay results in clinical settings.

Purpose of the Study:

• To identify and validate a novel test organism for accurate penicillin blood-level determination.
• To establish a sensitive and reliable method for routine clinical application.

Main Methods:

• Utilized a specific strain of Streptococcus dysgalactiae as the test organism.
• Determined the minimum inhibitory concentration (MIC) of penicillin for S. dysgalactiae.
• Assessed the resistance of S. dysgalactiae to natural inhibiting substances present in human blood sera.
• Evaluated the sensitivity of the assay for detecting penicillin in blood serum samples.

Main Results:

• Streptococcus dysgalactiae is inhibited by penicillin at concentrations of 0.006-0.008 unit/ml.
• This organism demonstrates significant resistance to natural inhibitors found in human blood sera.
• The developed assay method can accurately detect penicillin blood levels as low as 0.016 unit/ml.
• This sensitivity is adequate for routine clinical application, as therapeutic levels are typically above 0.03 unit/ml.

Conclusions:

• Streptococcus dysgalactiae is a suitable and effective test organism for penicillin blood-level assays.
• The new method offers improved accuracy and reliability compared to existing assays due to resistance to serum inhibitors.
• This assay is sensitive enough for routine clinical use in monitoring penicillin therapy.